Latest news with #SudhirSrivastava
Time of India
2 days ago
- Health
- Time of India
Indian doctors in France perform complex surgeries on 2 patients in Indore, courtesy robotics tech
Indian surgeons successfully performed two complex robotic surgeries in Indore while attending a conference in France, using the SSI Mantra Surgical Robotic System. The cross-continental procedures—a gastric bypass and a heart defect repair—showcased India's advancement in telesurgery, offering affordable, real-time medical expertise across borders using indigenous robotic technology. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Indian surgeons performed complex surgeries on two patients in Indore while attending a conference around 8,000 km away at Strasbourg in France, showcasing the effectiveness and major advancements in cross-continent robotic telesurgery The two procedures, a gastric bypass and a cardiac atrial septal defect (ASD) closure, were performed by two Indian surgeons at the annual conference of the Society of Robotic Surgery (SRS) held in Strasbourg using the indigenously developed SSI Mantra Surgical Robotic System The conference held from July 16-20 was attended by scientists, surgeons and medtech partners from across the first procedure, a gastric bypass, was performed by Dr Mohit Bhandari, president of IRCAD India and founder of Mohak Bariatrics and Robotics, Indore, on July out remotely from Strasbourg, the surgery lasted just over 44 minutes and was completed without second surgery, a robotic closure of an atrial septal defect (ASD), a form of congenital heart defect, was carried out by Dr Sudhir Srivastava, founder-chairman and CEO of SS Innovations International Inc., from Strasbourg while the patient remained in procedure was moderated live at the conference by Dr Husam H Balkhy, president of the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS), and director of robotic and minimally invasive cardiac surgery at the University of Chicago event served as a compelling demonstration of the growing feasibility of real-time, cross-continental surgical collaboration, Srivastava procedures were performed remotely from the Institut de recherche contre les cancers de l'appareil digestif (IRCAD) headquarters in Strasbourg at two medical centres in Indore -- Sri Aurobindo Institute of Medical Sciences (SAIMS) and IRCAD National in Indore, the patient-side support team ensured seamless coordination, led by Dr Lalit Malik, chief of cardiac surgery at Manipal Hospital, Jaipur; Dr Ram Krishna Shukla, cardiologist, and Dr Bipin Arya, anesthesiologist, both from SAIMS, procedures were supported by technical teams from both SS Innovations and SAIMS, ensuring real-time responsiveness and success of the surgeries highlights the viability of intercontinental robotic procedures as a real-world solution to longstanding healthcare access eliminating the need for travel and enabling remote expertise to be applied in real time, robotic telesurgery is redefining the boundaries of healthcare delivery - especially for patients in remote or underserved regions, Srivastava said."I am deeply grateful to Dr Vipul Patel, Dr Mohit Bhandari, the IRCAD India team, and everyone at SS Innovations for making the world's first intercontinental robotic cardiac telesurgery a reality."Importantly, such procedures are not only technically viable but also economically accessible, with costs comparable to conventional surgeries, typically ranging between Rs 80,000 and Rs 3.5 lakh, depending on the case and on the hospital, the complexity of the surgery, and the specific case requirements," Srivastava said, "Performing a complex gastric bypass remotely, across continents, marks a transformative moment in surgical science. It's not just about technological capability; it's about bridging gaps in access to quality healthcare."The success of the SSI Mantra system proves that the future of safe, precise, and inclusive surgery is here, and it's being shaped in India."At a conference dominated by global giants in medical technology, the execution of such high-stakes procedures using indigenous technology reflects a growing shift in innovation leadership and global collaboration in healthcare, he date, 35 telesurgeries - including 10 cardiac cases, and over 250 cardiac procedures - have been successfully completed using the SSI Mantra system, Srivastava Innovations International is the only surgical robotics company to have received regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) for both tele-proctoring and telesurgery in India , he said.
India Today
5 days ago
- Health
- India Today
From France to Indore: Surgery performed across 10,000 km using Indian robot system
Two surgeries were conducted 10,000 km apart with doctors seated in France while the patients lay in operating rooms in Indore, a made-in-India surgical robot, the procedures were carried out remotely in real time, marking a new development in the application of robotic telesurgery across operations, a gastric bypass and a cardiac atrial septal defect (ASD) closure, were performed at the Society of Robotic Surgery Conference held in Strasbourg, The surgeries linked teams at the Institut de recherche contre les cancers de l'appareil digestif (IRCAD) headquarters in Strasbourg with operation theatres at the Sri Aurobindo Institute of Medical Sciences (SAIMS) and the IRCAD National Centre in Indore. Both procedures were conducted using the SSI Mantra surgical robotic system, which has been developed in India by SS Innovations International, approved by India's Central Drugs Standard Control Organisation (CDSCO) for both tele-proctoring and to the medical teams involved, the system allowed surgeons in France to carry out the procedures with minimal delay or disruption, using robotic arms controlled gastric bypass, a weight-loss surgery, was conducted by Dr. Mohit Bhandari, President of IRCAD India, and reportedly took just over 44 minutes with no complications."Performing a complex gastric bypass remotely, across continents, marks a transformative moment in surgical science. It's not just about technological capability; it's about bridging gaps in access to quality healthcare. The success of the SSI Mantra system proves that the future of safe, precise, and inclusive surgery is here, and it's being shaped in India," said Dr. Mohit Bhandari. The second procedure, the ASD closure, was performed by Dr. Sudhir Srivastava, Chairman of SS Innovations, with the support of cardiologists and anaesthesiologists based in the technology of robotic-assisted surgery has been used for over two decades, what distinguishes this instance is the scale and distance of the complex surgeries across 10,000 km, in real-time, without latency issues, is a test of both the system's technical reliability and the infrastructure supporting it, especially internet bandwidth and teams in Indore provided surgical support and managing patient safety. According to SS Innovations, the robotic system has been used in over 5,000 surgeries across specialties, including 35 telesurgeries and 250 cardiac procedures. The company says no device-related complications have been reported so robotic telesurgery is not new globally, its application in intercontinental procedures is still rare. The ability to safely perform surgeries remotely could have implications for improving access to specialised care, particularly in regions where expert surgical teams are not easily Central Drugs Standard Control Organisation (CDSCO) has approved the SSI Mantra system for both telesurgery and remote training, making it one of the few systems in the country with such IS A ROBOTIC SURGERY? Robotic surgery is a type of operation where doctors use a machine with robotic arms to carry out surgical surgeon controls the robot using a computer and hand-held tools, guiding the robotic arms with great robot does not work on its own, it follows the doctor's exact movements. This kind of surgery can help doctors perform complex operations through small cuts, with more accuracy and control than traditional more data becomes available, the long-term clinical outcomes of such procedures will determine how widely this model can be adopted.- Ends
Yahoo
15-07-2025
- Business
- Yahoo
SS Innovations Surpasses Milestone of 100 Installations of the SSi Mantra Surgical Robotic System
Continuing strong procedure growth, including an upsurge in telesurgeries FORT LAUDERDALE, Fla., July 15, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the 'Company' or 'SS Innovations') (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company has installed more than 100 SSi Mantra surgical robotic systems in India and six other countries. To date, more than 5,000 surgical procedures have been successfully performed utilizing the SSi Mantra, including 240 cardiac surgeries and 32 telesurgeries. As of December 31, 2024, a total of 2,759 robotic surgeries had been successfully completed using the SSi Mantra, including 151 cardiac surgeries and 9 telesurgeries. Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, 'We are thrilled to surpass the milestone of 100 installations of our SSi Mantra surgical robotic system in India and beyond. We are seeing growing demand for and acceptance of the SSi Mantra, which reflects its premium quality, innovative features, ease of use, improved patient experience, and overall cost-effectiveness. We aim to democratize access to cutting edge robotic surgery through deploying SSi Mantra in existing markets while simultaneously pursuing new geographies. In that regard, we expect to submit a De Novo application for approval to market the SSi Mantra to the U.S. Food and Drug Administration by the end of July 2025 for multiple indications and continue along the pathway towards a European Union CE marking certification as soon as late 2025.' About SS Innovations SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company's product range includes its proprietary 'SSi Mantra' surgical robotic system and its comprehensive suite of 'SSi Mudra' surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company's website at or LinkedIn for more information and updates. About the SSi Mantra The SSi Mantra surgical robotic system is a user-friendly, modular, multi-arm system with many advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. A vision cart provides the table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra utilizes over 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery. The SSi Mantra has been clinically validated in India in more than 100 different types of surgical procedures. Forward Looking StatementsThis press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words 'anticipate,' 'assume,' 'believe,' 'estimate,' 'expect,' 'will,' 'intend,' 'may,' 'plan,' 'project,' 'should,' 'could,' 'seek,' 'designed,' 'potential,' 'forecast,' 'target,' 'objective,' 'goal,' or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SS Innovations' future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investor Contact:The Equity GroupKalle Ahl, CFAT: (303) 953-9878kahl@ Devin Sullivan, Managing Director T: (212) 836-9608dsullivan@ Media Contact:RooneyPartners LLCKate BarretteT: (212) 223-0561kbarrette@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Time of India
04-07-2025
- Health
- Time of India
Haryana Minister Rao Narbir Singh flags off Surgical Robot Yatra in Gurugram
Gurugram : Haryana's Minister for Industries and Commerce Rao Narbir Singh flagged off the SSI MantraM 'Made in India' Surgical Robot Yatra in Gurugram on Wednesday. With the launch of the SSI MantraM Surgical Robot Yatra, India embarks on a transformative journey in healthcare, unveiling its first mobile robotic surgery training and demonstration unit, said an official. This innovative "telesurgery-on-wheels" initiative brings cutting-edge surgical technology and skill-building opportunities directly to hospitals and healthcare professionals across the country, he added. According to an official statement, developed indigenously, the unit is equipped to enable real-time collaboration and demonstrate the advanced features and capabilities of the SSI Mantra Surgical Robotic System. Through live simulations, interactive training modules, and guided demonstrations, it offers surgeons, medical students, and healthcare stakeholders a first-hand experience. This initiative marks a step towards increasing awareness and acceptance of robotic surgery in India - particularly by making cutting-edge surgical technologies more accessible to tier two and tier three cities. The minister said that it is a matter of immense pride that Haryana is home to SS Innovations, a company leading India's charge in the global field of surgical robotics. Dr Sudhir Srivastava, founder chairman and CEO of SS Innovations, said, "SSI MantraM is more than just a mobile robotic training and demonstration unit, it is a national movement to democratise and decentralise access to world-class surgical education and innovation." PTI COR MNK MNK
Hans India
05-06-2025
- Business
- Hans India
Indian medtech startup rings bell in NY, celebrates Nasdaq debut
Hyderabad: In a defining leap for Indian medical technology on the global stage, SS Innovations International, the creators of the indigenous SSI Mantra surgical robotic system — rang the opening bell on Wednesday at the Nasdaq Market Site in New York City. The company's shares are listed under the ticker symbol 'SSII'. The ceremony was led by Dr Sudhir Srivastava, Founder, Chairman, and CEO of SS Innovations International, joined by members of the company's management team, Board of Directors, key advisors, and special guests. This milestone marks a proud moment for India, underscoring the nation's growing leadership in advanced medical technologies and heralding a new era of innovation and international recognition for Indian-origin healthcare solutions. SS Innovations International has made remarkable progress with its clinically validated and patented SSI Mantra Surgical Robotic System, which has been installed in 80 hospitals across 75 locations in India. The company has also expanded its presence internationally to countries including Nepal, Ecuador, Guatemala, the Philippines, Indonesia, Sri Lanka, Colombia and Ukraine. With over 4,000 successful robotic surgeries completed across more than 100 surgical procedures, the SSI Mantra is transforming access to advanced robotic surgery by offering a cost-effective solution to a broader patient population.
